SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

LYKA LABS

BSE: 500259 18 Aug 2025
Healthcare
₹ 100
Lyka Labs Ltd., specializes in Pharmaceuticals within the Healthcare sector.

LYKA LABS - Share Price & Details

Market Cap
₹360.0
High /Low
177.0 / 90.0
Stock P/E
48.0
Book Value
₹29.0
Dividend Yield
0.0
ROCE
9.91
ROE
₹9.21
Face Value
10.0
PEG Ratio
-1.12
EVEBITDA
₹19.7
Debt
39.2
CMP / FCF
-410.0
Debt to equity
₹0.38
NP Ann
7.93
High price all time
267.0
Piotroski score
₹5.0
Graham Number
37.0
No. Eq. Shares
3.57
Net CF
₹-4.60
Net profit
7.82
Price to book value
3.46
Interest Coverage
₹5.3
Low price all time
8.15
Industry PE
33.1
Reserves
₹67.9
Free Cash Flow
₹-10.4

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
LYKA LABS LTD.298.438.14291.760.22360.048.0
EVEREST ORGANICS LTD.411.5129.13409.351.3535657.3
MEDICO REMEDIES LIMITED389.118.18382.510.2235334.1

Peer Comparison Chart


About LYKA LABS

Lyka Labs Ltd.,, with Security Code 500259, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Check Point Software Technologies Ltd. Stock Analysis and Forecast - Build wealth faster with consistent investment plans

(04 Aug 2025)
【Investor Trends】✌️ Real data. Real results. Our top picks deliver massive growth — often above 200%.
Read more →

Lyka Labs First Quarter 2026 Earnings: EPS: ₹0.25 (vs ₹0.40 in 1Q 2025)

(03 Aug 2025)
Lyka Labs ( NSE:LYKALABS ) First Quarter 2026 Results Key Financial Results Revenue: ₹336.6m (up 12% from 1Q 2025). Net...
Read more →

Lyka Labs Reports Mixed Financial Results Amidst Significant Profit Growth and Operational Challenges

(02 Aug 2025)
Lyka Labs has reported its financial results for the quarter ending June 2025, showcasing a substantial increase in Profit After Tax to Rs 2.70 crore,...
Read more →

Lyka Labs consolidated net profit declines 35.42% in the June 2025 quarter

(01 Aug 2025)
Net profit of Lyka Labs declined 35.42% to Rs 0.93 crore in the quarter ended June 2025 as against Rs 1.44 crore during the previous quarter ended June 2024...
Read more →

Lyka Labs Limited (500259) Sees Unusual Trading Volume - Superior profit margins

(26 Jul 2025)
Lyka Labs Limited (500259) Sees Unusual Trading Volume ✌️【Stock Highlights】✌️ Professional-grade analytics and free investment tips in one...
Read more →

Lyka Labs Shows Strong Profit Growth Amidst Mixed Stock Performance Challenges

(26 Jul 2025)
Lyka Labs, a microcap in the Pharmaceuticals & Biotechnology sector, has recently adjusted its evaluation amid a shift in market sentiment.
Read more →

Company Updates